Production (Stage)
Harvard Apparatus Regenerative Technology Inc.
HRGN
$1.66
-$0.14-7.78%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 418.00K | 430.00K | 235.00K | 216.00K | 160.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 418.00K | 430.00K | 235.00K | 216.00K | 160.00K |
| Cost of Revenue | 291.00K | 270.00K | 106.00K | 49.00K | 36.00K |
| Gross Profit | 127.00K | 160.00K | 129.00K | 167.00K | 124.00K |
| SG&A Expenses | 5.00M | 5.14M | 5.19M | 5.21M | 4.92M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.29M | 7.66M | 7.92M | 7.67M | 8.28M |
| Operating Income | -6.88M | -7.23M | -7.69M | -7.45M | -8.12M |
| Income Before Tax | -7.36M | -7.73M | -8.21M | -7.97M | -8.09M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.36 | -7.73 | -8.21 | -7.97 | -8.09 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.36M | -7.73M | -8.21M | -7.97M | -8.09M |
| EBIT | -6.88M | -7.23M | -7.69M | -7.45M | -8.12M |
| EBITDA | -6.87M | -7.21M | -7.67M | -7.43M | -8.10M |
| EPS Basic | -0.49 | -0.53 | -0.58 | -0.57 | -0.58 |
| Normalized Basic EPS | -0.28 | -0.31 | -0.34 | -0.33 | -0.36 |
| EPS Diluted | -0.49 | -0.53 | -0.58 | -0.57 | -0.58 |
| Normalized Diluted EPS | -0.28 | -0.31 | -0.34 | -0.33 | -0.36 |
| Average Basic Shares Outstanding | 61.12M | 59.15M | 57.15M | 56.02M | 55.55M |
| Average Diluted Shares Outstanding | 61.12M | 59.15M | 57.15M | 56.02M | 55.55M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |